TY - JOUR AU - Shariat, S. F. AU - Roehrborn, C. G. PY - 2008 DA - 2008// TI - Using biopsy to detect prostate cancer JO - Rev Urol VL - 10 ID - Shariat2008 ER - TY - STD TI - de la Taille A, Antiphon P, Salomon L, Cherfan M, Porcher R, Hoznek A, Saint F, Vordos D, Cicco A, Yiou R et al. Prospective evaluation of a 21-sample needle biopsy procedure designed to improve the prostate cancer detection rate. Urology. 2003;61(6):1181–6. ID - ref2 ER - TY - JOUR AU - Ferdinandusse, S. AU - Denis, S. AU - IJIst, L. AU - Dacremont, G. AU - Waterham, H. R. AU - Wanders, R. J. PY - 2000 DA - 2000// TI - Subcellular localization and physiological role of alpha-methylacyl-CoA racemase JO - J Lipid Res VL - 41 ID - Ferdinandusse2000 ER - TY - STD TI - Rubin MA, Zhou M, Dhanasekaran SM, Varambally S, Barrette TR, Sanda MG, Pienta KJ, Ghosh D Chinnaiyan AM. alpha-methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. JAMA. 2002;287(13):1662–70. ID - ref4 ER - TY - JOUR AU - Ananthanarayanan, V. AU - Deaton, R. J. AU - Yang, X. J. AU - Pins, M. R. AU - Gann, P. H. PY - 2005 DA - 2005// TI - Alpha-methylacyl-CoA racemase (AMACR) expression in normal prostatic glands and high-grade prostatic intraepithelial neoplasia (HGPIN): association with diagnosis of prostate cancer JO - Prostate VL - 63 UR - https://doi.org/10.1002/pros.20196 DO - 10.1002/pros.20196 ID - Ananthanarayanan2005 ER - TY - JOUR AU - Gologan, A. AU - Bastacky, S. AU - McHale, T. AU - Yu, J. AU - Cai, C. AU - Monzon-Bordonaba, F. AU - Dhir, R. PY - 2005 DA - 2005// TI - Age-associated changes in alpha-methyl CoA racemase (AMACR) expression in nonneoplastic prostatic tissues JO - Am J Surg Pathol VL - 29 UR - https://doi.org/10.1097/01.pas.0000180855.66948.5e DO - 10.1097/01.pas.0000180855.66948.5e ID - Gologan2005 ER - TY - JOUR AU - Andersson, S. AU - Berman, D. M. AU - Jenkins, E. P. AU - Russell, D. W. PY - 1991 DA - 1991// TI - Deletion of steroid 5 alpha-reductase 2 gene in male pseudohermaphroditism JO - Nature VL - 354 UR - https://doi.org/10.1038/354159a0 DO - 10.1038/354159a0 ID - Andersson1991 ER - TY - STD TI - Koivisto P, Kononen J, Palmberg C, Tammela T, Hyytinen E, Isola J, Trapman J, Cleutjens K, Noordzij A, Visakorpi T et al. Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer. Cancer Res. 1997;57(2):314–9. ID - ref8 ER - TY - STD TI - Bubendorf L, Kononen J, Koivisto P, Schraml P, Moch H, Gasser TC, Willi N, Mihatsch MJ, Sauter G, Kallioniemi OP. Survey of gene amplifications during prostate cancer progression by high throughput fluorescence in situ hybridization on tissue microarrays. Cancer Res. 1999;59(4):803–6. ID - ref9 ER - TY - STD TI - Luo J, Zha S, Gage WR, Dunn TA, Hicks JL, Bennett CJ,Ewing CM, Platz EA, Ferdinandusse S, Wanders RJ et al. Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer. Cancer Res. 2002;62(8):2220–6. ID - ref10 ER - TY - STD TI - Neves AF, Araujo TG, Biase WK, Meola J, Alcantara TM, Freitas DG, Goulart LR. Combined analysis of multiple mRNA markers by RT-PCR assay for prostate cancer diagnosis. Clin Biochem. 2008;41(14–15):1191–8. ID - ref11 ER - TY - STD TI - Jiang Z, Wu CL, Woda BA, Dresser K, Xu J, Fanger GR, Yang XJ. P504S/alpha-methylacyl-CoA racemase: a useful marker for diagnosis of small foci of prostatic carcinoma on needle biopsy. Am J Surg Pathol. 2002;26(9):1169–74. ID - ref12 ER - TY - STD TI - Beach R, Gown AM, De Peralta-Venturina MN, Folpe AL, Yaziji H, Salles PG, Grignon DJ, Fanger GR, Amin MB. P504S immunohistochemical detection in 405 prostatic specimens including 376 18-gauge needle biopsies. Am J Surg Pathol. 2002;26(12):1588–96. ID - ref13 ER - TY - STD TI - Visakorpi T, Hyytinen E, Koivisto P, Tanner M, Keinanen R, Palmberg C, Palotie A, Tammela T, Isola J, Kallioniemi OP. In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat Genet. 1995;9(4):401–6. ID - ref14 ER - TY - STD TI - Vaananen RM, Rissanen M, Kauko O, Junnila S, Vaisanen V, Nurmi J, Pettersson K. Quantitative real-time RT-PCR assay for PCA3. Clin Biochem. 2008;41(1–2):103–8. ID - ref15 ER - TY - STD TI - Riina-Minna Väänänen, Natalia Tong Ochoa, Peter J Boström, Pekka Taimen, Kim Pettersson. Altered PCA3 and TMPRSS2-ERG expression in histologically benign regions of cancerous prostates: a systematic, quantitative mRNA analysis in five prostates. BMC Urol. 2015;15:88. doi: 10.1186/s12894-015-0077-7 ID - ref16 ER - TY - JOUR AU - Nurmi, J. AU - Lilja, H. AU - Ylikoski, A. PY - 2000 DA - 2000// TI - Time-resolved fluorometry in end-point and real-time PCR quantification of nucleic acids JO - Luminescence VL - 15 UR - https://doi.org/3.0.CO;2-3 DO - 3.0.CO;2-3 ID - Nurmi2000 ER - TY - STD TI - Rissanen M, Helo P, Vaananen RM, Wahlroos V, Lilja H, Nurmi M, Pettersson K, Nurmi Jl. Novel homogenous time-resolved fluorometric RT-PCR assays for quantification of PSA and hK2 mRNAs in blood. Clin Biochem. 2007;40(1–2):111–8. ID - ref18 ER - TY - STD TI - Alinezhad S, Vaananen RM, Lehmusvuori A, Karhunen U, Soukka T, Kahkonen E, Taimen P, Alanen K, Pettersson K. Lanthanide chelate complementation and hydrolysis enhanced luminescent chelate in real-time reverse transcription polymerase chain reaction assays for KLK3 transcripts. Anal Biochem. 2014;444:1–7. ID - ref19 ER - TY - STD TI - Vaananen RM, Lilja H, Cronin A, Kauko L, Rissanen M, Kauko O, Kekki H, Vidback S, Nurmi M, Alanen K et al. Association of transcript levels of 10 established or candidate-biomarker gene targets with cancerous versus non-cancerous prostate tissue from radical prostatectomy specimens. \Clin Biochem. 2013;46(7–8):670–4. ID - ref20 ER - TY - JOUR AU - Patel, A. R. AU - Jones, J. S. AU - Rabets, J. AU - DeOreo, G. AU - Zippe, C. D. PY - 2004 DA - 2004// TI - Parasagittal biopsies add minimal information in repeat saturation prostate biopsy JO - Urology VL - 63 UR - https://doi.org/10.1016/j.urology.2003.08.040 DO - 10.1016/j.urology.2003.08.040 ID - Patel2004 ER - TY - JOUR AU - Stewart, C. S. AU - Leibovich, B. C. AU - Weaver, A. L. AU - Lieber, M. M. PY - 2001 DA - 2001// TI - Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies JO - J Urology VL - 166 UR - https://doi.org/10.1016/S0022-5347(05)66083-1 DO - 10.1016/S0022-5347(05)66083-1 ID - Stewart2001 ER - TY - STD TI - Jiang Z, Woda BA, Rock KL, Xu Y, Savas L, Khan A, Pihan G, Cai F, Babcook JS, Rathanaswami P et al. P504S: a new molecular marker for the detection of prostate carcinoma. Am J Surg Pathol. 2001;25(11):1397–404. ID - ref23 ER - TY - JOUR AU - Kristiansen, G. PY - 2009 DA - 2009// TI - [Immunohistochemical algorithms in prostate diagnostics: what’s new?] JO - Pathologe VL - 30 UR - https://doi.org/10.1007/s00292-009-1230-4 DO - 10.1007/s00292-009-1230-4 ID - Kristiansen2009 ER - TY - STD TI - Nickens KP, Ali A, Scoggin T, Tan SH, Ravindranath L, McLeod DG, Dobi A, Tacha D, Sesterhenn IA, Srivastava S et al. Prostate cancer marker panel with single cell sensitivity in urine. Prostate. 2015;75(9):969–75. ID - ref25 ER - TY - STD TI - Kumar-Sinha C, Shah RB, Laxman B, Tomlins SA, Harwood J, Schmitz W, Conzelmann E, Sanda MG, Wei JT, Rubin MA et al. Elevated alpha-methylacyl-CoA racemase enzymatic activity in prostate cancer. Am J Pathol. 2004;164(3):787–93. ID - ref26 ER - TY - STD TI - Ouyang B, Leung YK, Wang V, Chung E, Levin L, Bracken B, Cheng L, Ho SM. alpha-Methylacyl-CoA racemase spliced variants and their expression in normal and malignant prostate tissues. Urology. 2011;77(1):249. e241-247. ID - ref27 ER - TY - STD TI - Laxman B, Morris DS, Yu J, Siddiqui J, Cao J, Mehra R, Lonigro RJ, Tsodikov A, Wei JT, Tomlins SA et all. A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer. Cancer Res. 2008;68(3):645–9. ID - ref28 ER - TY - JOUR AU - Ogden, G. R. AU - Cowpe, J. G. AU - Green, M. W. PY - 1990 DA - 1990// TI - Evidence of field change in oral cancer JO - Br J Oral Maxillofac Surg VL - 28 UR - https://doi.org/10.1016/0266-4356(90)90036-K DO - 10.1016/0266-4356(90)90036-K ID - Ogden1990 ER - TY - JOUR AU - Popa, I. AU - Fradet, Y. AU - Beaudry, G. AU - Hovington, H. AU - Tetu, B. PY - 2007 DA - 2007// TI - Identification of PCA3 (DD3) in prostatic carcinoma by in situ hybridization JO - Mod Pathol VL - 20 UR - https://doi.org/10.1038/modpathol.3800963 DO - 10.1038/modpathol.3800963 ID - Popa2007 ER - TY - JOUR AU - Slaughter, D. P. AU - Southwick, H. W. AU - Smejkal, W. PY - 1953 DA - 1953// TI - Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin JO - Cancer VL - 6 UR - https://doi.org/3.0.CO;2-Q DO - 3.0.CO;2-Q ID - Slaughter1953 ER - TY - JOUR AU - Hockel, M. AU - Dornhofer, N. PY - 2005 DA - 2005// TI - The hydra phenomenon of cancer: why tumors recur locally after microscopically complete resection JO - Cancer Res VL - 65 ID - Hockel2005 ER - TY - STD TI - Yamada H, Tsuzuki T, Maeda N, Yamauchi Y, Yoshida S, Ishida R, Nishikimi T, Yokoi K, Kobayashi H. Alpha methylacyl-CoA racemase (AMACR) in prostate adenocarcinomas from Japanese patients: Is AMACR a “race”-dependent marker? Prostate. 2013;73(1):54–9. ID - ref33 ER - TY - JOUR AU - Magi-Galluzzi, C. AU - Luo, J. AU - Isaacs, W. B. AU - Hicks, J. L. AU - Marzo, A. M. AU - Epstein, J. I. PY - 2003 DA - 2003// TI - Alpha-methylacyl-CoA racemase: a variably sensitive immunohistochemical marker for the diagnosis of small prostate cancer foci on needle biopsy JO - Am J Surg Pathol VL - 27 UR - https://doi.org/10.1097/00000478-200308000-00010 DO - 10.1097/00000478-200308000-00010 ID - Magi-Galluzzi2003 ER -